Do elevated triglycerides and large VLDL particles indicate increased TRL production and atherogenic remnant exposure?

The relationship between elevated triglycerides, large VLDL particles, and cardiovascular risk is well-established through genetic, clinical, and mechanistic research. These markers serve as primary indicators of a metabolic environment characterized by the overproduction of triglyceride-rich lipoproteins (TRLs) and the subsequent accumulation of atherogenic remnants.

Clinical evidence and cardiovascular risk

• Large-scale epidemiological data, including the Copenhagen General Population Study (n > 100,000), demonstrate that every 1 mmol/L (39 mg/dL) increase in remnant cholesterol is associated with a 2.8-fold increase in the risk of ischemic heart disease, independent of LDL cholesterol levels.
• Mendelian randomization studies provide causal evidence, showing that genetic variants leading to higher VLDL and IDL cholesterol levels (components of remnant cholesterol) significantly increase the odds of coronary artery disease (OR ~1.4) and myocardial infarction.

Mechanistic pathways of atherogenicity

• Production and Conversion: In states of insulin resistance or lipid overload, the liver preferentially secretes large VLDL1 particles (60–200 nm). As these particles undergo lipolysis by lipoprotein lipase (LPL), they transition into cholesterol-enriched remnants and intermediate-density lipoproteins (IDL).
• Intimal Entrapment: Unlike larger chylomicrons, VLDL remnants are small enough to penetrate the arterial intima, where they bind to proteoglycans like biglycan. This "response-to-retention" leads to prolonged subendothelial accumulation.
• Direct Macrophage Uptake: Remnant particles are uniquely atherogenic because they can be taken up directly by macrophages via scavenger receptors without requiring oxidative modification. This bypasses the regulatory control of the LDL receptor, accelerating foam cell formation and plaque progression.

Bottom line

Elevated triglycerides and large VLDL particles are clinically validated markers of increased TRL production and remnant cholesterol exposure. Because remnants cause direct macrophage foam cell formation and arterial inflammation, they represent a primary and causal driver of atherosclerotic cardiovascular disease.